Daily Roundup

AVA.ASX RMD.ASX ANZ.ASX EQR.ASX COL.ASX

Strong Q3 for AVA Risk Group, Resmed Declares Dividend, and ANZ Reports Solid Half-Year Results

AVA Risk Group reported a solid Q3 FY2026, with $6.1 million in sales order intake and a $21.7 million year-to-date tally. The company also secured a $6.2 million sales order backlog, including $2.6 million in recurring revenue. Notably, AVA completed a $7 million strategic investment from Hale Capital, providing growth capital to support its U.S. expansion plans.

Resmed Inc. had an impressive quarter, with revenue increasing 11% to $1.4 billion. The company saw 290 basis points of non-GAAP gross margin expansion and an 18% rise in non-GAAP operating income. Resmed also declared a quarterly dividend of $0.06 per share, payable on June 18, 2026.

Turning to the banking sector, ANZ Group Holdings reported a 14% increase in cash profit for the first half of 2026. The company's statutory profit remained unchanged at $3,650 million, while cash profit rose to $3,780 million. ANZ also announced a proposed 2026 interim dividend of 83 cents per share, partially franked at 75%.

The bank is making good progress on its strategic initiatives, including the integration of Suncorp Bank and the rollout of a single customer front-end. ANZ is targeting estimated gross cost savings of $800 million in the 2026 financial year, with 49% of this target already realized.

Overall, it's been a busy day for the Australian market, with several companies delivering solid financial results and shareholder-friendly announcements. Investors will no doubt be keeping a close eye on these developments as the year progresses.